InvestorsHub Logo
Followers 99
Posts 2761
Boards Moderated 2
Alias Born 02/10/2004

Re: RedShoulder post# 177

Sunday, 01/23/2005 12:19:47 AM

Sunday, January 23, 2005 12:19:47 AM

Post# of 8201
greeneyedhawk. As I postec to terry on RB, I think there's good reason to believe the AMRIS acquisition was more than a deffensive move. Here's why I think so:

I think there's good reason to suspect there's more to it than just a quick take-under of a competitve tech.. We already know that AMRIS has been doing R&D with BSX for their microwire conductor MRI-visibility solution. Of course we also know BIPH is doing R&D with BSX and is negotiating a term sheet with BSX that stipulates exclusive and non-exclusive terms for various BIPH technologies.

Considering the rush BIPH seams to be in to finalize the acquisition of AMRIS (completing DD and finalizing the transaction by the end of this month) seams to be more than a coincidence.

I think this might pan-out more like BIPHs acquisition of Te-Bio on 5/15/04 (for the biothermal power source).....and the rather quick announcement only 3 months later (8/17/04) of a development agreement with NASA for that biothermal power source they just acquired 3 months earlier. I gaurantee BIPH needed to do mre than 3 months work to get the NASA agreement. They probably worked on that for at least several more months prior to that 3 month time frame.
http://www.biophan.com/pr/release_051404.html
http://www.biophan.com/pr/081704NASAAmes.html

I believe this could ultimately prove to be the case with AMRIS....it's just too coincidental that AMRIS and BIPH have both been working with BSX on similar solutions.... Then BIPH uses this language of exclusive and non-exclusive terms. This makes me ponder and speculate that BSX might get exclusivity to the AMRISs stent solution, while BIPHs coatings get non-exclusive terms so the coating. This will allow the coatings to become an industry standard to be applied to a variety of devices to increase the compatibility of other interventional tools, procedures, and devices to
move towards MRI-compatibility. This general market awareness and broad market acceptance of interventional MRI would ultimately benefit BSX...especially if the have some ownership in BIPH....and especially if hey retained exclusivity for the "gold standard".

That's just my stab in the dark......but I obviously think it's more than just a deffensive move.



"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854